GWSG
MED icon

GPS Wealth Strategies Group’s Medifast MED Stock Holding History

GPS Wealth Strategies Group’s Portfolio MED Stock Details MED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-40
Closed -$7K – 1159
2022
Q2 		$7K Hold
40
– – ﹤0.01% 826
2022
Q1 		$7K Hold
40
– – ﹤0.01% 795
2021
Q4 		$8K Hold
40
– – ﹤0.01% 777
2021
Q3 		$8K Buy
+40
New +$9.83K ﹤0.01% 763

Other funds holding MED

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

GPS Wealth Strategies Group's MED Position: Q3 2022 in Review

GPS Wealth Strategies Group sold out of Medifast (MED) in Q3 2022, closing a stake of 40 shares — an estimated $7K sold.

GPS Wealth Strategies Group first reported a position in MED in Q3 2021 and held it in 4 quarters. The position peaked at $8K in Q4 2021. 263 funds tracked by Wall St. Rank hold MED as of Q3 2022.

  • GPS Wealth Strategies Group reported no remaining Medifast position as of Q3 2022 after selling out during the quarter.
  • GPS Wealth Strategies Group sold 40 Medifast shares in Q3 2022, an estimated $7K.
  • GPS Wealth Strategies Group first reported a position in Medifast in Q3 2021 and held it in 4 quarters.
  • GPS Wealth Strategies Group's Medifast position peaked at $8K in Q4 2021.
  • 263 funds tracked by Wall St. Rank held Medifast as of Q3 2022.

Based on GPS Wealth Strategies Group's 13F filing for Q3 2022, filed 17 Oct 2022.